Related Experiment Video
Updated: Aug 6, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features
John Best1, Marianne Chapleau1, Gil D Rabinovici1,2
1Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Posterior Cortical Atrophy (PCA) is a rare neurodegenerative condition affecting vision and cognition, often misdiagnosed. Early diagnosis is crucial for managing Alzheimer's disease, the most common cause.
Area of Science:
- Neurodegenerative Disorders
- Neuroscience
- Ophthalmology
Background:
- Posterior Cortical Atrophy (PCA) is a neurodegenerative syndrome primarily affecting higher-order visual processing due to parietal and occipital lobe atrophy.
- While the underlying pathology varies, Alzheimer's disease is the most frequent cause, with symptom onset typically before age 65.
- Delayed diagnosis is common, as symptoms are often mistaken for ocular issues rather than cortical dysfunction.
Approach:
- This review provides a comprehensive analysis of Posterior Cortical Atrophy (PCA) syndrome.
- It covers clinical presentations, neuroimaging findings, pathological hallmarks, and genetic factors.
- Management strategies and therapeutic interventions are also discussed.
Key Points:
- Patients often present with visual-perceptual and visuospatial deficits, with other cognitive impairments developing over time.
- Neuroimaging reveals predominant parieto-occipital or temporo-occipital atrophy.
- Cerebrospinal fluid biomarkers and amyloid/tau PET imaging aid in diagnosing underlying Alzheimer's disease.
Conclusions:
- Management of PCA primarily relies on non-pharmacological interventions.
- Prompt etiological diagnosis is essential, particularly with the advent of disease-modifying therapies for Alzheimer's disease.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests